Global Tinea Corporis Treatment Market Growth (Status and Outlook) 2022-2028
The global market for Tinea Corporis Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Tinea Corporis Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Tinea Corporis Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Tinea Corporis Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Tinea Corporis Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Tinea Corporis Treatment players cover Perrigo Company, Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals, Inc., Glenmark Pharmaceuticals Inc. and Breckenridge Pharmaceutical, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Tinea Corporis Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Tinea Corporis Treatment market, with both quantitative and qualitative data, to help readers understand how the Tinea Corporis Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Tinea Corporis Treatment market and forecasts the market size by Type (Topical and Oral,), by Application (Hospital Pharmacy, Retail Pharmacy and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Topical
Oral
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Perrigo Company
Taro Pharmaceuticals U.S.A., Inc.
Teva Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Inc.
Breckenridge Pharmaceutical, Inc.
NorthStar Rx LLC
Aurobindo Pharma Limited
Camber Pharmaceuticals, Inc.
AvKare, Inc.
Novartis AG
Sebela Pharmaceuticals, Inc.
Bayer AG
Blueberry Therapeutics Ltd
Chapter Introduction
Chapter 1: Scope of Tinea Corporis Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Tinea Corporis Treatment market size and CAGR, Tinea Corporis Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Tinea Corporis Treatment revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Tinea Corporis Treatment revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Tinea Corporis Treatment market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Perrigo Company, Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals, Inc., Glenmark Pharmaceuticals Inc., Breckenridge Pharmaceutical, Inc., NorthStar Rx LLC, Aurobindo Pharma Limited, Camber Pharmaceuticals, Inc. and AvKare, Inc., etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tinea Corporis Treatment Market Size 2017-2028
2.1.2 Tinea Corporis Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Tinea Corporis Treatment Segment by Type
2.2.1 Topical
2.2.2 Oral
2.3 Tinea Corporis Treatment Market Size by Type
2.3.1 Tinea Corporis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Tinea Corporis Treatment Market Size Market Share by Type (2017-2022)
2.4 Tinea Corporis Treatment Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Tinea Corporis Treatment Market Size by Application
2.5.1 Tinea Corporis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Tinea Corporis Treatment Market Size Market Share by Application (2017-2022)
3 Tinea Corporis Treatment Market Size by Player
3.1 Tinea Corporis Treatment Market Size Market Share by Players
3.1.1 Global Tinea Corporis Treatment Revenue by Players (2020-2022)
3.1.2 Global Tinea Corporis Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Tinea Corporis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Tinea Corporis Treatment by Regions
4.1 Tinea Corporis Treatment Market Size by Regions (2017-2022)
4.2 Americas Tinea Corporis Treatment Market Size Growth (2017-2022)
4.3 APAC Tinea Corporis Treatment Market Size Growth (2017-2022)
4.4 Europe Tinea Corporis Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Tinea Corporis Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Tinea Corporis Treatment Market Size by Country (2017-2022)
5.2 Americas Tinea Corporis Treatment Market Size by Type (2017-2022)
5.3 Americas Tinea Corporis Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tinea Corporis Treatment Market Size by Region (2017-2022)
6.2 APAC Tinea Corporis Treatment Market Size by Type (2017-2022)
6.3 APAC Tinea Corporis Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Tinea Corporis Treatment by Country (2017-2022)
7.2 Europe Tinea Corporis Treatment Market Size by Type (2017-2022)
7.3 Europe Tinea Corporis Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tinea Corporis Treatment by Region (2017-2022)
8.2 Middle East & Africa Tinea Corporis Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Tinea Corporis Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Tinea Corporis Treatment Market Forecast
10.1 Global Tinea Corporis Treatment Forecast by Regions (2023-2028)
10.1.1 Global Tinea Corporis Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Tinea Corporis Treatment Forecast
10.1.3 APAC Tinea Corporis Treatment Forecast
10.1.4 Europe Tinea Corporis Treatment Forecast
10.1.5 Middle East & Africa Tinea Corporis Treatment Forecast
10.2 Americas Tinea Corporis Treatment Forecast by Country (2023-2028)
10.2.1 United States Tinea Corporis Treatment Market Forecast
10.2.2 Canada Tinea Corporis Treatment Market Forecast
10.2.3 Mexico Tinea Corporis Treatment Market Forecast
10.2.4 Brazil Tinea Corporis Treatment Market Forecast
10.3 APAC Tinea Corporis Treatment Forecast by Region (2023-2028)
10.3.1 China Tinea Corporis Treatment Market Forecast
10.3.2 Japan Tinea Corporis Treatment Market Forecast
10.3.3 Korea Tinea Corporis Treatment Market Forecast
10.3.4 Southeast Asia Tinea Corporis Treatment Market Forecast
10.3.5 India Tinea Corporis Treatment Market Forecast
10.3.6 Australia Tinea Corporis Treatment Market Forecast
10.4 Europe Tinea Corporis Treatment Forecast by Country (2023-2028)
10.4.1 Germany Tinea Corporis Treatment Market Forecast
10.4.2 France Tinea Corporis Treatment Market Forecast
10.4.3 UK Tinea Corporis Treatment Market Forecast
10.4.4 Italy Tinea Corporis Treatment Market Forecast
10.4.5 Russia Tinea Corporis Treatment Market Forecast
10.5 Middle East & Africa Tinea Corporis Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Tinea Corporis Treatment Market Forecast
10.5.2 South Africa Tinea Corporis Treatment Market Forecast
10.5.3 Israel Tinea Corporis Treatment Market Forecast
10.5.4 Turkey Tinea Corporis Treatment Market Forecast
10.5.5 GCC Countries Tinea Corporis Treatment Market Forecast
10.6 Global Tinea Corporis Treatment Forecast by Type (2023-2028)
10.7 Global Tinea Corporis Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Perrigo Company
11.1.1 Perrigo Company Company Information
11.1.2 Perrigo Company Tinea Corporis Treatment Product Offered
11.1.3 Perrigo Company Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Perrigo Company Main Business Overview
11.1.5 Perrigo Company Latest Developments
11.2 Taro Pharmaceuticals U.S.A., Inc.
11.2.1 Taro Pharmaceuticals U.S.A., Inc. Company Information
11.2.2 Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Product Offered
11.2.3 Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Taro Pharmaceuticals U.S.A., Inc. Main Business Overview
11.2.5 Taro Pharmaceuticals U.S.A., Inc. Latest Developments
11.3 Teva Pharmaceuticals, Inc.
11.3.1 Teva Pharmaceuticals, Inc. Company Information
11.3.2 Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Product Offered
11.3.3 Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Teva Pharmaceuticals, Inc. Main Business Overview
11.3.5 Teva Pharmaceuticals, Inc. Latest Developments
11.4 Glenmark Pharmaceuticals Inc.
11.4.1 Glenmark Pharmaceuticals Inc. Company Information
11.4.2 Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Product Offered
11.4.3 Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Glenmark Pharmaceuticals Inc. Main Business Overview
11.4.5 Glenmark Pharmaceuticals Inc. Latest Developments
11.5 Breckenridge Pharmaceutical, Inc.
11.5.1 Breckenridge Pharmaceutical, Inc. Company Information
11.5.2 Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Product Offered
11.5.3 Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Breckenridge Pharmaceutical, Inc. Main Business Overview
11.5.5 Breckenridge Pharmaceutical, Inc. Latest Developments
11.6 NorthStar Rx LLC
11.6.1 NorthStar Rx LLC Company Information
11.6.2 NorthStar Rx LLC Tinea Corporis Treatment Product Offered
11.6.3 NorthStar Rx LLC Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 NorthStar Rx LLC Main Business Overview
11.6.5 NorthStar Rx LLC Latest Developments
11.7 Aurobindo Pharma Limited
11.7.1 Aurobindo Pharma Limited Company Information
11.7.2 Aurobindo Pharma Limited Tinea Corporis Treatment Product Offered
11.7.3 Aurobindo Pharma Limited Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Aurobindo Pharma Limited Main Business Overview
11.7.5 Aurobindo Pharma Limited Latest Developments
11.8 Camber Pharmaceuticals, Inc.
11.8.1 Camber Pharmaceuticals, Inc. Company Information
11.8.2 Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Product Offered
11.8.3 Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Camber Pharmaceuticals, Inc. Main Business Overview
11.8.5 Camber Pharmaceuticals, Inc. Latest Developments
11.9 AvKare, Inc.
11.9.1 AvKare, Inc. Company Information
11.9.2 AvKare, Inc. Tinea Corporis Treatment Product Offered
11.9.3 AvKare, Inc. Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 AvKare, Inc. Main Business Overview
11.9.5 AvKare, Inc. Latest Developments
11.10 Novartis AG
11.10.1 Novartis AG Company Information
11.10.2 Novartis AG Tinea Corporis Treatment Product Offered
11.10.3 Novartis AG Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Novartis AG Main Business Overview
11.10.5 Novartis AG Latest Developments
11.11 Sebela Pharmaceuticals, Inc.
11.11.1 Sebela Pharmaceuticals, Inc. Company Information
11.11.2 Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Product Offered
11.11.3 Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sebela Pharmaceuticals, Inc. Main Business Overview
11.11.5 Sebela Pharmaceuticals, Inc. Latest Developments
11.12 Bayer AG
11.12.1 Bayer AG Company Information
11.12.2 Bayer AG Tinea Corporis Treatment Product Offered
11.12.3 Bayer AG Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Bayer AG Main Business Overview
11.12.5 Bayer AG Latest Developments
11.13 Blueberry Therapeutics Ltd
11.13.1 Blueberry Therapeutics Ltd Company Information
11.13.2 Blueberry Therapeutics Ltd Tinea Corporis Treatment Product Offered
11.13.3 Blueberry Therapeutics Ltd Tinea Corporis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Blueberry Therapeutics Ltd Main Business Overview
11.13.5 Blueberry Therapeutics Ltd Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Tinea Corporis Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Topical
Table 3. Major Players of Oral
Table 4. Tinea Corporis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Tinea Corporis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Tinea Corporis Treatment Market Size Market Share by Type (2017-2022)
Table 7. Tinea Corporis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Tinea Corporis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Tinea Corporis Treatment Market Size Market Share by Application (2017-2022)
Table 10. Global Tinea Corporis Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Tinea Corporis Treatment Revenue Market Share by Player (2020-2022)
Table 12. Tinea Corporis Treatment Key Players Head office and Products Offered
Table 13. Tinea Corporis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Tinea Corporis Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Tinea Corporis Treatment Market Size Market Share by Regions (2017-2022)
Table 18. Americas Tinea Corporis Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Tinea Corporis Treatment Market Size Market Share by Country (2017-2022)
Table 20. Americas Tinea Corporis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Tinea Corporis Treatment Market Size Market Share by Type (2017-2022)
Table 22. Americas Tinea Corporis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Tinea Corporis Treatment Market Size Market Share by Application (2017-2022)
Table 24. APAC Tinea Corporis Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Tinea Corporis Treatment Market Size Market Share by Region (2017-2022)
Table 26. APAC Tinea Corporis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Tinea Corporis Treatment Market Size Market Share by Type (2017-2022)
Table 28. APAC Tinea Corporis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Tinea Corporis Treatment Market Size Market Share by Application (2017-2022)
Table 30. Europe Tinea Corporis Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Tinea Corporis Treatment Market Size Market Share by Country (2017-2022)
Table 32. Europe Tinea Corporis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Tinea Corporis Treatment Market Size Market Share by Type (2017-2022)
Table 34. Europe Tinea Corporis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Tinea Corporis Treatment Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Tinea Corporis Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Tinea Corporis Treatment Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Tinea Corporis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Tinea Corporis Treatment Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Tinea Corporis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Tinea Corporis Treatment Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Tinea Corporis Treatment
Table 43. Key Market Challenges & Risks of Tinea Corporis Treatment
Table 44. Key Industry Trends of Tinea Corporis Treatment
Table 45. Global Tinea Corporis Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Tinea Corporis Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Tinea Corporis Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Tinea Corporis Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Tinea Corporis Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Tinea Corporis Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 51. Perrigo Company Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 52. Perrigo Company Tinea Corporis Treatment Product Offered
Table 53. Perrigo Company Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Perrigo Company Main Business
Table 55. Perrigo Company Latest Developments
Table 56. Taro Pharmaceuticals U.S.A., Inc. Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 57. Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Product Offered
Table 58. Taro Pharmaceuticals U.S.A., Inc. Main Business
Table 59. Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Taro Pharmaceuticals U.S.A., Inc. Latest Developments
Table 61. Teva Pharmaceuticals, Inc. Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 62. Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Product Offered
Table 63. Teva Pharmaceuticals, Inc. Main Business
Table 64. Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Teva Pharmaceuticals, Inc. Latest Developments
Table 66. Glenmark Pharmaceuticals Inc. Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 67. Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Product Offered
Table 68. Glenmark Pharmaceuticals Inc. Main Business
Table 69. Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Glenmark Pharmaceuticals Inc. Latest Developments
Table 71. Breckenridge Pharmaceutical, Inc. Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 72. Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Product Offered
Table 73. Breckenridge Pharmaceutical, Inc. Main Business
Table 74. Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Breckenridge Pharmaceutical, Inc. Latest Developments
Table 76. NorthStar Rx LLC Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 77. NorthStar Rx LLC Tinea Corporis Treatment Product Offered
Table 78. NorthStar Rx LLC Main Business
Table 79. NorthStar Rx LLC Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. NorthStar Rx LLC Latest Developments
Table 81. Aurobindo Pharma Limited Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 82. Aurobindo Pharma Limited Tinea Corporis Treatment Product Offered
Table 83. Aurobindo Pharma Limited Main Business
Table 84. Aurobindo Pharma Limited Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Aurobindo Pharma Limited Latest Developments
Table 86. Camber Pharmaceuticals, Inc. Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 87. Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Product Offered
Table 88. Camber Pharmaceuticals, Inc. Main Business
Table 89. Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Camber Pharmaceuticals, Inc. Latest Developments
Table 91. AvKare, Inc. Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 92. AvKare, Inc. Tinea Corporis Treatment Product Offered
Table 93. AvKare, Inc. Main Business
Table 94. AvKare, Inc. Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. AvKare, Inc. Latest Developments
Table 96. Novartis AG Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 97. Novartis AG Tinea Corporis Treatment Product Offered
Table 98. Novartis AG Main Business
Table 99. Novartis AG Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Novartis AG Latest Developments
Table 101. Sebela Pharmaceuticals, Inc. Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 102. Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Product Offered
Table 103. Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Sebela Pharmaceuticals, Inc. Main Business
Table 105. Sebela Pharmaceuticals, Inc. Latest Developments
Table 106. Bayer AG Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 107. Bayer AG Tinea Corporis Treatment Product Offered
Table 108. Bayer AG Main Business
Table 109. Bayer AG Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Bayer AG Latest Developments
Table 111. Blueberry Therapeutics Ltd Details, Company Type, Tinea Corporis Treatment Area Served and Its Competitors
Table 112. Blueberry Therapeutics Ltd Tinea Corporis Treatment Product Offered
Table 113. Blueberry Therapeutics Ltd Main Business
Table 114. Blueberry Therapeutics Ltd Tinea Corporis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Blueberry Therapeutics Ltd Latest Developments
List of Figures
List of Figures
Figure 1. Tinea Corporis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tinea Corporis Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Tinea Corporis Treatment Market Size Market Share by Type in 2021
Figure 7. Tinea Corporis Treatment in Hospital Pharmacy
Figure 8. Global Tinea Corporis Treatment Market: Hospital Pharmacy (2017-2022) & ($ Millions)
Figure 9. Tinea Corporis Treatment in Retail Pharmacy
Figure 10. Global Tinea Corporis Treatment Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Tinea Corporis Treatment in Others
Figure 12. Global Tinea Corporis Treatment Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Tinea Corporis Treatment Market Size Market Share by Application in 2021
Figure 14. Global Tinea Corporis Treatment Revenue Market Share by Player in 2021
Figure 15. Global Tinea Corporis Treatment Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Tinea Corporis Treatment Market Size 2017-2022 ($ Millions)
Figure 17. APAC Tinea Corporis Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Europe Tinea Corporis Treatment Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Tinea Corporis Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Americas Tinea Corporis Treatment Value Market Share by Country in 2021
Figure 21. Americas Tinea Corporis Treatment Consumption Market Share by Type in 2021
Figure 22. Americas Tinea Corporis Treatment Market Size Market Share by Application in 2021
Figure 23. United States Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Tinea Corporis Treatment Market Size Market Share by Region in 2021
Figure 28. APAC Tinea Corporis Treatment Market Size Market Share by Application in 2021
Figure 29. China Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Tinea Corporis Treatment Market Size Market Share by Country in 2021
Figure 36. Europe Tinea Corporis Treatment Market Size Market Share by Type in 2021
Figure 37. Europe Tinea Corporis Treatment Market Size Market Share by Application in 2021
Figure 38. Germany Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Tinea Corporis Treatment Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Tinea Corporis Treatment Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Tinea Corporis Treatment Market Size Market Share by Application in 2021
Figure 46. Egypt Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Tinea Corporis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 52. APAC Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 53. Europe Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 55. United States Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Canada Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 59. China Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Japan Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Korea Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 63. India Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Australia Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Germany Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 66. France Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 67. UK Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Italy Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Russia Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Spain Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Israel Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Tinea Corporis Treatment Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets